company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4862000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4862000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,162000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,437000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,352000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3855000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3855000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-185000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-407000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-644000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1236000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1236000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,108000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4939000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,5986000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,124000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11157000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11157000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6066000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3607000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3607000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1039000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-591000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,832000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3148000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5475000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5475000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-152000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1387000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,518000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1021000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1021000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11250000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4754000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1129000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4371000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4371000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,203000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1163000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13191000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16196000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16196000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-87000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,670000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,121000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,698000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,698000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1988000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-35000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,561000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13538000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13538000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1960000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8195000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8195000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,343000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1085000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,432000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6335000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6335000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-584000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49391000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,254000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-584000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50412000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50412000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1370000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,35000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,101092000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,102497000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,102337000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,45590000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4731000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4731000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1319000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,967000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6174000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8619000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8619000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-101000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2464000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43802000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15627000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-30742000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-30742000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1112000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40473000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9125000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9125000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1759000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1861000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16237000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10732000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10732000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-110000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2673000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-75081000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-924000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78997000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,650000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,859000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,859000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-988000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-43000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4141000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-31000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3079000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3079000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14670000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3499000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8289000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8289000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1633000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1741000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18217000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23132000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23132000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1411000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67401000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,99830000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,23000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31034000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31034000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37140000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-774000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,90000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-37824000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-37824000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29922000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4716000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4716000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1536000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1829000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4803000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3452000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3452000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-474000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18884000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16823000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2552000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2552000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,205000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,105000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,105000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1005000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3750000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3750000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2029000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2893000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,67000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1239000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1239000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1658000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58612000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62284000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1984000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1984000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,290000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,280000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,280000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3503000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,798000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2907000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5324000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1681000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1681000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,295000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-107195000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,109525000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-399000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2169000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2169000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,410000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,410000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,410000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,898000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1021000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9838000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9838000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1274000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3446000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7659000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6899000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6899000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-92000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-111000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99648000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,93200000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6651000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6651000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,183000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,183000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,183000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,431000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13370000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13370000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,822000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1255000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7454000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,20391000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,20391000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8022000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26320000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29675000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4686000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4686000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,171000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,171000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,171000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15876000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2826000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2826000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2070000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1216000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1653000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4459000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4459000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-672000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1546000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-94751000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23653000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-73316000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-73316000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,70832000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,70832000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,70776000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1943000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3560000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3560000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2908000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,758000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10576000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17802000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17802000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-320000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8491000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54479000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50200000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,586000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12504000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12504000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8872000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-31000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3605000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,652000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5119000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5119000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1750000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,915000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12179000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4395000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4395000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-556000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-989000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21784000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21250000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2079000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2079000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10324000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,149000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10175000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10175000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,55000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16594000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3069000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3069000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2761000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-238000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18419000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,24011000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,24011000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1264000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-557000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30966000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30797000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1990000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1990000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,174000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,174000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,174000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-102000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22093000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1926000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1926000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1796000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,304000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4175000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-149000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-149000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1055000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4817000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28248000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,122675000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,88555000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,88555000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-75000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,102000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,27000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,27000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,88449000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3217000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1954000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25368000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2732000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2732000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1367000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-84508000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6173000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6630000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-85418000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-85418000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-306000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1152000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,598000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,980000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2424000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2424000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-385000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-80647000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1361000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2555000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1894000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1894000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3089000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,205000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1596000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2996000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2996000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2240000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-100000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2464000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3804000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3804000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5476000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,165000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5311000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5311000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-164000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6283000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-256000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-256000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3038000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,454000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7927000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4691000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4691000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-953000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-668000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2757000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2450000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1928000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1928000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-159000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8251000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8092000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8092000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,122000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1595000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1795000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1795000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2669000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,908000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12975000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11193000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11193000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1864000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12126000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4981000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4870000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14101000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14101000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-164000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1001000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-638000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25095000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17937000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17937000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4885000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,45975000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-27558000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5365000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5365000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1654000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-598000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3010000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3100000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2162000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2162000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-135000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-72000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,92000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-115000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-115000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3112000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,414000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4340000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4988000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4988000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1703000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6699000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20041000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16627000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16627000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2339000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1694000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2003000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2036000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2036000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1663000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3135000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1472000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1472000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,733000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16458000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-517000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-517000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2712000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,719000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1084000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1830000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1830000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3713000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,1694000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5213000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1800000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5100000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1694000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2026000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2026000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1697000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4831000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,93000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3227000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3227000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3020000.0
